Products

OmicsArray™ Standard Pre-Designed Peptide Microarrays

Ready-to-Screen Panels for Infectious Disease, Autoimmunity, and Oncology GeneCopoeia offers a diverse catalog of pre-designed peptide microarrays for full-service screening. These panels are designed by scientists to cover specific proteomes or immunodominant...

Cell Lines for Immuno-oncology Research

Explore our resources below to see how we can support your oncology and immuno-oncology studies. CAR-T Target Luciferase-labeled Cancer Cell Lines The luciferase-labeled cancer cell lines were modified from the wild-type cancer cell lines and stably expresses firefly...

Tumor Associated Antigen Array, 60-Plex

[tab:Product Information] Tumor-associated autoantibodies (TAAbs) are promising biomarkers for early cancer detection, monitoring, and prognosis because the immune system creates them in response to tumor-associated antigens (TAAs) long before symptoms appear. While...

HEK293T / anti-CD3 (OKT3) Stable Cell Line

This stable cell line is the HEK293T cell line stably expressing the OKT3, OKT3 is the monoclonal antibody name for CD3. The stable expression of the single-chain variable fragment (scFv) of OKT3 enables the cell line to mimic...

Tumor Associated Antigen Array, 60-Plex

[tab:Product Information] Tumor-associated autoantibodies (TAAbs) are promising biomarkers for early cancer detection, monitoring, and prognosis because the immune system creates them in response to...

OncoSpot™ NGS Spike-in Reference Standards

Genecopoeia provides OncoSpot™ NGS Spike-in Reference Standards for monitoring the whole process of the detection. The CRISPR method is employed to modify the genome of tumour cells, introducing single nucleotide mutations or in-frame indel mutations. Concurrently, spike-in markers are set up using our patented technology ‘DNA reference standard and use thereof’.

read more

Protease

Introduction Proteases are widely distributed in animals, plants, and microorganisms, and their main role is to...

read more